Targeted delivery of doxorubicin in liver cancer | IJN - Dove Medical Press
A DOX conjugate with liver tumor targeting and acid sensitivity based on a short aromatic peptide FFYEE
Introduction
Doxorubicin (DOX) is an anthracycline antitumor drug with superiority and broad spectrum of therapeutic efficacy.1,2 After uptake by cells, DOX exerts its efficacy mainly by noncovalent… [+32545 chars]
Read More
Other Stories in Health
- Can gut microbes help prevent Alzheimer’s?
- Who really decides what Australians eat? New study reveals financial sector’s hidden power
- Genetic diversity of malaria parasite challenges one size fits all strategies
- How can chia seed water reduce belly fat?
- New fitness metric may predict heart disease risk better than steps or heart rate, finds study
- New assay detects epigenetic changes caused by carcinogenic chemicals
- Refining the diagnosis of large granular lymphocytic leukemias and their mimics
- Capturing the true meaning of quality in health services
- Akbar to Jahangir: How Mughal emperors used royal footwear to flaunt their power
.png)
